REPORT ID 13430

EMEA (Europe, Middle East and Africa) Foot and Mouth Disease (FMD) Vaccines Market Report 2017

Publish Date
21-Nov-17
Pages
122
Format
Electronic (PDF)

In this report, the EMEA Foot and Mouth Disease (FMD) Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Foot and Mouth Disease (FMD) Vaccines market competition by top manufacturers/players, with Foot and Mouth Disease (FMD) Vaccines sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    MSD Animal Health
    Bayer HealthCare
    Sanofi(Merial)
    Brilliant Bio Pharma
    Agrovet
    Inova Biotecnologia Sa?de Animal Ltda.
    Indian Immunologicals
    Middle East Veterinary Vaccine
    Botswana Vaccine Institute
    Centro Diagn?stico Veterinario
    VETAL Animal Health
    Veterinary Serum
    Biog nesis S. A.
    Veterinarios S.A.
    Limor de Colombia
    Razi Vaccine & Serum Research Institute
    Intervac (PVT) Ltd.
    CAHIC
    Tecon Group
    Jinyu Group
    China Animal Healthcare
    BI WEI ANTAI BIOLOGICAL
    Cavet Bio
    QYH Biotech

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    O- type FMD inactivated vaccine
    FMD O type synthetic peptide vaccine
    Inactivated vaccine
    Bivalent inactivated vaccine
    Trivalent inactivated vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines for each application, including
    Pig
    Cattle
    Sheep
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Foot and Mouth Disease (FMD) Vaccines Market Report 2017
1 Foot and Mouth Disease (FMD) Vaccines Overview
    1.1 Product Overview and Scope of Foot and Mouth Disease (FMD) Vaccines
    1.2 Classification of Foot and Mouth Disease (FMD) Vaccines
        1.2.1 EMEA Foot and Mouth Disease (FMD) Vaccines Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Foot and Mouth Disease (FMD) Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 O- type FMD inactivated vaccine
        1.2.4 FMD O type synthetic peptide vaccine
        1.2.5 Inactivated vaccine
        1.2.6 Bivalent inactivated vaccine
        1.2.7 Trivalent inactivated vaccine
    1.3 EMEA Foot and Mouth Disease (FMD) Vaccines Market by Application/End Users
        1.3.1 EMEA Foot and Mouth Disease (FMD) Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Pig
        1.3.3 Cattle
        1.3.4 Sheep
        1.3.5 Others
    1.4 EMEA Foot and Mouth Disease (FMD) Vaccines Market by Region
        1.4.1 EMEA Foot and Mouth Disease (FMD) Vaccines Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Foot and Mouth Disease (FMD) Vaccines (2012-2022)
        1.5.1 EMEA Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA Foot and Mouth Disease (FMD) Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Foot and Mouth Disease (FMD) Vaccines Market Competition by Players/Manufacturers
        2.1.1 EMEA Foot and Mouth Disease (FMD) Vaccines Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Foot and Mouth Disease (FMD) Vaccines Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Foot and Mouth Disease (FMD) Vaccines Sale Price by Players (2012-2017)
    2.2 EMEA Foot and Mouth Disease (FMD) Vaccines (Volume and Value) by Type/Product Category
        2.2.1 EMEA Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Foot and Mouth Disease (FMD) Vaccines Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Foot and Mouth Disease (FMD) Vaccines Sale Price by Type (2012-2017)
    2.3 EMEA Foot and Mouth Disease (FMD) Vaccines (Volume) by Application
    2.4 EMEA Foot and Mouth Disease (FMD) Vaccines (Volume and Value) by Region
        2.4.1 EMEA Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Foot and Mouth Disease (FMD) Vaccines Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Foot and Mouth Disease (FMD) Vaccines Sales Price by Region (2012-2017)

3 Europe Foot and Mouth Disease (FMD) Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales and Value (2012-2017)
        3.1.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2012-2017)
    3.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type
    3.3 Europe Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Application
    3.4 Europe Foot and Mouth Disease (FMD) Vaccines Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Volume by Countries (2012-2017)
        3.4.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Countries (2012-2017)
        3.4.3 Germany Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        3.4.4 France Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        3.4.5 UK Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        3.4.6 Russia Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        3.4.7 Italy Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)

4 Middle East Foot and Mouth Disease (FMD) Vaccines (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Foot and Mouth Disease (FMD) Vaccines Sales and Value (2012-2017)
        4.1.1 Middle East Foot and Mouth Disease (FMD) Vaccines Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2012-2017)
    4.2 Middle East Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type
    4.3 Middle East Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Application
    4.4 Middle East Foot and Mouth Disease (FMD) Vaccines Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Foot and Mouth Disease (FMD) Vaccines Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Foot and Mouth Disease (FMD) Vaccines Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        4.4.4 Israel Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        4.4.5 UAE Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        4.4.6 Iran Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)

5 Africa Foot and Mouth Disease (FMD) Vaccines (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Foot and Mouth Disease (FMD) Vaccines Sales and Value (2012-2017)
        5.1.1 Africa Foot and Mouth Disease (FMD) Vaccines Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2012-2017)
    5.2 Africa Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type
    5.3 Africa Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Application
    5.4 Africa Foot and Mouth Disease (FMD) Vaccines Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Foot and Mouth Disease (FMD) Vaccines Sales Volume by Countries (2012-2017)
        5.4.2 Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Countries (2012-2017)
        5.4.3 South Africa Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2012-2017)

6 EMEA Foot and Mouth Disease (FMD) Vaccines Manufacturers/Players Profiles and Sales Data
    6.1 MSD Animal Health
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Foot and Mouth Disease (FMD) Vaccines Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bayer HealthCare
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Foot and Mouth Disease (FMD) Vaccines Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Sanofi(Merial)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Foot and Mouth Disease (FMD) Vaccines Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Sanofi(Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Brilliant Bio Pharma
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Foot and Mouth Disease (FMD) Vaccines Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Agrovet
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Foot and Mouth Disease (FMD) Vaccines Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Inova Biotecnologia Sa?de Animal Ltda.
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Foot and Mouth Disease (FMD) Vaccines Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Inova Biotecnologia Sa?de Animal Ltda. Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Indian Immunologicals
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Foot and Mouth Disease (FMD) Vaccines Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Middle East Veterinary Vaccine
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Foot and Mouth Disease (FMD) Vaccines Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Middle East Veterinary Vaccine Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Botswana Vaccine Institute
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Foot and Mouth Disease (FMD) Vaccines Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Botswana Vaccine Institute Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Centro Diagn?stico Veterinario
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Foot and Mouth Disease (FMD) Vaccines Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Centro Diagn?stico Veterinario Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 VETAL Animal Health
    6.12 Veterinary Serum
    6.13 Biog nesis S. A.
    6.14 Veterinarios S.A.
    6.15 Limor de Colombia
    6.16 Razi Vaccine & Serum Research Institute
    6.17 Intervac (PVT) Ltd.
    6.18 CAHIC
    6.19 Tecon Group
    6.20 Jinyu Group
    6.21 China Animal Healthcare
    6.22 BI WEI ANTAI BIOLOGICAL
    6.23 Cavet Bio
    6.24 QYH Biotech

7 Foot and Mouth Disease (FMD) Vaccines Manufacturing Cost Analysis
    7.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Foot and Mouth Disease (FMD) Vaccines Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Foot and Mouth Disease (FMD) Vaccines Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Foot and Mouth Disease (FMD) Vaccines Market Forecast (2017-2022)
    11.1 EMEA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Foot and Mouth Disease (FMD) Vaccines Price and Trend Forecast (2017-2022)
    11.2 EMEA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Type (2017-2022)
    11.7 EMEA Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer